Genmab A/S
STABLE IgG4 ANTIBODIES
Last updated:
Abstract:
The present invention relates to novel stabilized IgG4 antibodies, to methods of producing such antibodies and to uses of such antibodies as a medicament. In a main aspect, the invention relates to a stabilized IgG4 antibody, comprising a heavy chain and a light chain, wherein said heavy chain comprises a human IgG4 constant region having a substitution of the Arg residue at position (409), the Phe residue at position (405) or the Lys residue at position (370).
Status:
Application
Type:
Utility
Filling date:
15 Jul 2020
Issue date:
4 Mar 2021